Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Scleroderma
Research
Ventoux drug slows fibrosis in mouse model of hand condition
Industry veteran Kurt Harrington, who has Dupuytren's contracture, hopes his startup's drug will add an option for a condition with few treatments.
Helen Floersh
Mar 12, 2024 11:00am
Anaptys picks up rival to Biogen autoimmune asset from Centessa
Nov 28, 2023 6:30am
New autoimmunity mechanism explains why B cells self-react
Oct 2, 2023 8:45am
Sanofi joins scleroderma trial initiative as 1st partner
Aug 1, 2023 11:03am
Ex-Shire drug improves outcomes in phase 2 autoimmune trial
Feb 6, 2023 6:15am
